Compare Wockhardt with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs DR. REDDYS LAB - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT DR. REDDYS LAB WOCKHARDT/
DR. REDDYS LAB
 
P/E (TTM) x -53.8 39.9 - View Chart
P/BV x 1.2 5.4 22.1% View Chart
Dividend Yield % 0.0 0.4 0.7%  

Financials

 WOCKHARDT   DR. REDDYS LAB
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
DR. REDDYS LAB
Mar-19
WOCKHARDT/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0122,875 35.2%   
Low Rs5321,888 28.2%   
Sales per share (Unadj.) Rs355.9930.2 38.3%  
Earnings per share (Unadj.) Rs-60.3117.4 -51.3%  
Cash flow per share (Unadj.) Rs-46.8185.8 -25.2%  
Dividends per share (Unadj.) Rs0.0120.00 0.1%  
Dividend yield (eoy) %00.8 0.2%  
Book value per share (Unadj.) Rs257.8844.4 30.5%  
Shares outstanding (eoy) m110.63166.07 66.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.22.6 84.7%   
Avg P/E ratio x-12.820.3 -63.1%  
P/CF ratio (eoy) x-16.512.8 -128.7%  
Price / Book Value ratio x3.02.8 106.1%  
Dividend payout %017.0 -0.1%   
Avg Mkt Cap Rs m85,379395,496 21.6%   
No. of employees `0006.322.0 28.5%   
Total wages/salary Rs m9,37133,562 27.9%   
Avg. sales/employee Rs Th6,295.07,032.8 89.5%   
Avg. wages/employee Rs Th1,498.31,527.9 98.1%   
Avg. net profit/employee Rs Th-1,066.3887.7 -120.1%   
INCOME DATA
Net Sales Rs m39,369154,482 25.5%  
Other income Rs m1,2023,375 35.6%   
Total revenues Rs m40,571157,857 25.7%   
Gross profit Rs m1831,782 0.1%  
Depreciation Rs m1,49511,348 13.2%   
Interest Rs m2,555889 287.4%   
Profit before tax Rs m-2,83022,920 -12.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2573,858 6.7%   
Profit after tax Rs m-6,66919,500 -34.2%  
Gross profit margin %020.6 0.2%  
Effective tax rate %-9.116.8 -54.0%   
Net profit margin %-16.912.6 -134.2%  
BALANCE SHEET DATA
Current assets Rs m33,796111,101 30.4%   
Current liabilities Rs m26,91758,973 45.6%   
Net working cap to sales %17.533.7 51.8%  
Current ratio x1.31.9 66.6%  
Inventory Days Days7979 100.0%  
Debtors Days Days8994 94.7%  
Net fixed assets Rs m39,664101,245 39.2%   
Share capital Rs m553830 66.7%   
"Free" reserves Rs m27,968139,406 20.1%   
Net worth Rs m28,522140,236 20.3%   
Long term debt Rs m21,73122,000 98.8%   
Total assets Rs m81,620224,656 36.3%  
Interest coverage x-0.126.8 -0.4%   
Debt to equity ratio x0.80.2 485.7%  
Sales to assets ratio x0.50.7 70.1%   
Return on assets %-5.09.1 -55.5%  
Return on equity %-23.413.9 -168.1%  
Return on capital %-7.714.9 -51.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80788,673 11.1%   
Fx outflow Rs m1,78919,104 9.4%   
Net fx Rs m8,01969,569 11.5%   
CASH FLOW
From Operations Rs m68428,704 2.4%  
From Investments Rs m6,302-7,727 -81.6%  
From Financial Activity Rs m-7,695-21,326 36.1%  
Net Cashflow Rs m-664-314 211.5%  

Share Holding

Indian Promoters % 74.5 25.5 292.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 5.4 42.6%  
FIIs % 7.7 35.3 21.8%  
ADR/GDR % 0.1 18.5 0.5%  
Free float % 15.4 15.3 100.7%  
Shareholders   67,757 75,885 89.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Aug 7, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS